Skip to main content
Clinical Trials/EUCTR2005-000751-15-IT
EUCTR2005-000751-15-IT
Active, not recruiting
Not Applicable

CLINICAL STUDY OF APPRAISAL OF THE EFFECTIVENESS OF 1,25 (OH)2D3 (CALCITRIOL) TOWARDS PLACEBO IN THE DIABETES OF TYPE 1 OF RECENET INSORGENCE (IMDIAB XIII)

IVERSITA' CAMPUS BIOMEDICO0 sites80 target enrollmentJuly 25, 2005

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
GLICOMETABOLIC CONTROL AND ENDOGENOUS INSULIN SECRETION
Sponsor
IVERSITA' CAMPUS BIOMEDICO
Enrollment
80
Status
Active, not recruiting
Last Updated
14 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 25, 2005
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
IVERSITA' CAMPUS BIOMEDICO

Eligibility Criteria

Inclusion Criteria

  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) no
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials